Ascletis Announces Co-formulation of ASC36, Once-Monthly Next-Generation Amylin Receptor Agonist and ASC35, Once-Monthly Next-Generation GLP-1R/GIPR Dual Agonist for Clinical Development
- Using Ascletis' proprietary Ultra-Long-Acting Platform technology, co-formulation of ASC36, a once-monthly subcutaneously administered amylin receptor peptide agonist and ASC35, a once-monthly subcutaneously administered GLP-1R/GIPR dual peptide agonist, demonstrated a comparable pharmacokinetic (PK) profile to ASC36 and ASC35 dosed alone in head-to-head non-human primate studies. - ASC36 monotherapy demonstrated approximately 32% greater relative body weight reduction compared to eloralintide...
Starwood Pet Travel Reports 800% Growth in Pet Relocations Linked to Healthcare Workers Moving to New Zealand
CAPE CORAL, Fla., Nov. 13, 2025 /PRNewswire/ -- Starwood Pet Travel, a global leader in international pet relocation, has reported an 800% increase in relocations since 2019, driven in part by a surge of doctors, nurses, and other medical professionals moving to New Zealand with their pets. According to the Medical Council...
Focusing on Industrialisation and Exploring Global Pathways — The 3rd CREATE Symposium Concludes Successfully
HONG KONG, Nov. 12, 2025 /PRNewswire/ -- How is artificial intelligence revolutionising diagnostic experiences? How can robotics enhance surgical precision? How far are we from achieving universal access to medical AI? What are the latest trends and future directions in medical technology development? These hotly debated topics, which have captured widespread social attention, were comprehensively addressed by dozens of leading...
Medit and OraQ Announce Strategic Partnership to Advance AI-Driven Intelligence in Digital Dentistry
Collaboration unites two leaders in innovation to redefine how clinical insight is delivered across the dental ecosystem NEWPORT BEACH, Calif., Nov. 12, 2025 /PRNewswire/ -- Medit, a global leader in 3D intraoral scanning solutions, and OraQ, a pioneer in AI-powered clinical intelligence, today announced a strategic partnership designed to accelerate the integration...
World Gym Q3 Results: EPS Jumps 82.5% on Record Revenue
Record Revenue Up 14.1% Year-over-Year; EPS Jumps 82.5% to NT$1.04 TAIPEI, Nov. 12, 2025 /PRNewswire/ -- World Gym Corporation (2762.TW), the owner of the iconic global World Gym brand, today announced record third-quarter results for the period that ended September 30, 2025, underscoring continued growth momentum and improving margins. Financial Performance Revenue...
Wellness Innercell Expands into Indonesian Market
SEOUL, South Korea, Nov. 12, 2025 /PRNewswire/ -- Korean cosmetics manufacturing and health supplement distribution company Wellness Innercell is set to enter the Indonesian home shopping market. The company's flagship health supplement product, "Joint care" will be featured on major Indonesian home shopping channels between October and November this year. Through this broadcast, Wellness Innercell aims to showcase the excellence...
EirGenix Signed The Commercial Licensinse Agreement for It’s Second HER2 Biosimilar Asset EG1206A
TAIPEI, Nov. 12, 2025 /PRNewswire/ -- EirGenix Inc.(TWSE: 6589) today announced that it has entered into a second global exclusive licensing agreement with international biosimilar leader Sandoz AG (SIX:SDZ/OTCQX:SDZNY) for the commercialization of its independently developed breast cancer biosimilar, EG1206A (Pertuzumab Biosimilar to Roche Perjeta®), covering all territories except Taiwan, Mainland China, Macau, South Korea, Mongolia, Brunei, Cambodia,...
Vieworks Completes Major Expansion of Hwaseong Manufacturing Site, Doubling Production Capacity
Strategic Infrastructure Growth Positions Vieworks at the Forefront of Global Imaging Innovation ANYANG, South Korea, Nov. 12, 2025 /PRNewswire/ -- Vieworks, a global leader in advanced X-ray imaging and industrial vision systems, has announced the successful completion of a large-scale expansion at its Hwaseong manufacturing campus, significantly increasing production capacity and operational flexibility to meet growing global demand....
Alpha IVF Singapore uses Advanced Fertility Genomic Screening and Artificial Intelligence Embryo Scoring to help couples become parents
SINGAPORE, Nov. 12, 2025 /PRNewswire/ -- In-vitro fertilisation (IVF) has become increasingly prominent due to societal shifts towards delayed childbearing, infertility issues, and advances in medical technology that have improved success rates. At Alpha IVF Singapore, Advanced Fertility Genomic Screening and Artificial Intelligence – Enhanced Embryo Scoring are among the cutting-edge innovations...
CureGene Unveils Groundbreaking Preclinical Data for CG-0416, a Novel Oral Non-GLP-1 Therapy, at Obesity Week 2025
CG-0416, a highly liver-targeted THR-β agonist, demonstrates high-quality weight loss by reducing fat mass while preserving muscle, both as a monotherapy and in combination with GLP-1 RAs. ATLANTA, Nov. 12, 2025 /PRNewswire/ -- CureGene Pharmaceuticals ("CureGene") today announced the first disclosure of groundbreaking preclinical data for CG-0416, a novel oral non-GLP-1 weight-loss agent, in the Late-Breaking poster session (Poster-350)...
